XML 14 R4.htm IDEA: XBRL DOCUMENT v3.22.2.2
CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE INCOME (LOSS) - USD ($)
shares in Thousands, $ in Thousands
 3 Months Ended 9 Months Ended
Sep. 30, 2022
Sep. 30, 2021
Sep. 30, 2022
Sep. 30, 2021
Income Statement [Abstract]        
Revenue [1] $ 352,585 $ 222,471 $ 969,581 $ 659,599
Expenses        
Cost of revenue (exclusive of depreciation and amortization expenses presented separately below) [1] 266,617 163,126 736,061 493,071
Selling, general and administrative expenses [1] 68,521 51,292 186,408 152,582
Depreciation and amortization expenses 17,196 14,859 47,414 44,962
Change in fair value of contingent consideration (12,700) (225) (5,822) (819)
Total operating expenses 339,634 229,052 964,061 689,796
Operating income (loss) 12,951 (6,581) 5,520 (30,197)
Interest income 425 120 765 311
Interest expense (4,754) (6,367) (9,143) (18,978)
Gain from equity method investees 1,392 63 3,940 12,725
Gain on transfer of membership 0 0 0 22,969
Loss on extinguishment/repayment of debt (10,192) 0 (10,192) (19,158)
Change in tax receivable agreement liability (42,870) 0 (42,870) 0
Other income (expense), net (345) (41) 130 (73)
Loss from continuing operations before income taxes (43,393) (12,806) (51,850) (32,401)
Provision for (benefit from) income taxes (45,516) 234 (44,498) 936
Income (loss) from continuing operations 2,123 (13,040) (7,352) (33,337)
Income (loss) from discontinued operations, net of tax [2] 0 0 (463) 1,383
Net income (loss) attributable to common shareholders of Evolent Health, Inc. 2,123 (13,040) (7,815) (31,954)
Net loss attributable to common shareholders of Evolent Health, Inc. - Diluted $ 2,123 $ (13,040) $ (7,815) $ (31,954)
Basic:        
Continuing operations (in dollars per share) $ 0.02 $ (0.15) $ (0.08) $ (0.39)
Discontinued operations (in dollars per share) 0 0 (0.01) 0.02
Basic income (loss) per share attributable to common shareholders of Evolent Health, Inc. (in dollars per share) 0.02 (0.15) (0.09) (0.37)
Diluted:        
Continuing operations (in dollars per share) 0.02 (0.15) (0.08) (0.39)
Discontinued operations (in dollars per share) 0 0 (0.01) 0.02
Diluted income (loss) per share attributable to common shareholders of Evolent Health, Inc. (in dollars per share) $ 0.02 $ (0.15) $ (0.09) $ (0.37)
Weighted-average common shares outstanding        
Basic (in shares) 95,286 85,800 91,643 85,306
Diluted (in shares) 99,308 85,800 91,643 85,306
Comprehensive income (loss)        
Net income (loss) $ 2,123 $ (13,040) $ (7,815) $ (31,954)
Other comprehensive income (loss), net of taxes, related to:        
Foreign currency translation adjustment (262) 4 (682) (85)
Total comprehensive income (loss) attributable to common shareholders of Evolent Health, Inc. $ 1,861 $ (13,036) $ (8,497) $ (32,039)
[1] See Note 18 for amounts attributable to unconsolidated related parties included in these line items.
[2] Includes $(0.5) million loss on disposal of discontinued operations for the nine months ended September 30, 2022 and $1.9 million gain on disposal of discontinued operations for the nine months ended September 30, 2021, respectively